Modulation of Tau Pathology in Alzheimer's Disease by Dietary Bioactive Compounds

Huahua Shi,Yan Zhao

DOI: https://doi.org/10.3390/ijms25020831

IF: 5.6

2024-01-10

International Journal of Molecular Sciences

Abstract:Tau is a microtubule-associated protein essential for microtubule assembly and stability in neurons. The abnormal intracellular accumulation of tau aggregates is a major characteristic of brains from patients with Alzheimer's disease (AD) and other tauopathies. In AD, the presence of neurofibrillary tangles (NFTs), which is composed of hyperphosphorylated tau protein, is positively correlated with the severity of the cognitive decline. Evidence suggests that the accumulation and aggregation of tau cause synaptic dysfunction and neuronal degeneration. Thus, the prevention of abnormal tau phosphorylation and elimination of tau aggregates have been proposed as therapeutic strategies for AD. However, currently tau-targeting therapies for AD and other tauopathies are limited. A number of dietary bioactive compounds have been found to modulate the posttranslational modifications of tau, including phosphorylation, small ubiquitin-like modifier (SUMO) mediated modification (SUMOylation) and acetylation, as well as inhibit tau aggregation and/or promote tau degradation. The advantages of using these dietary components over synthetic substances in AD prevention and intervention are their safety and accessibility. This review summarizes the mechanisms leading to tau pathology in AD and highlights the effects of bioactive compounds on the hyperphosphorylation, aggregation and clearance of tau protein. The potential of using these bioactive compounds for AD prevention and intervention is also discussed.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The paper primarily explores the role of dietary bioactive compounds in regulating Tau protein pathology in Alzheimer's disease (AD). Specifically, the paper attempts to address the following issues:

1. **Abnormal Phosphorylation and Aggregation of Tau Protein**:
- The paper highlights the function of Tau protein under normal physiological conditions and its abnormal phosphorylation in pathological states. Tau protein is a microtubule-associated protein that promotes microtubule assembly and stability in neurons. However, under pathological conditions, Tau protein undergoes abnormal phosphorylation, leading to a decreased ability to bind to microtubules and the formation of toxic Tau aggregates.

2. **Various Modifications of Tau Protein**:
- In addition to phosphorylation, Tau protein undergoes various other post-translational modifications, such as SUMOylation, acetylation, and ubiquitination. These modifications significantly impact the function and aggregation of Tau protein.

3. **Mechanisms of Action of Dietary Bioactive Compounds**:
- Research has found that some dietary bioactive compounds (such as green tea polyphenol EGCG, curcumin, or resveratrol) can reduce the excessive phosphorylation of Tau protein and improve cognitive impairment in animal models of Alzheimer's disease. The safety and availability of these compounds make them potential means for the prevention and intervention of AD.

In summary, the paper aims to summarize the pathological mechanisms of Tau protein in AD and emphasize the potential of dietary bioactive compounds in regulating excessive phosphorylation, aggregation, and clearance of Tau protein, providing a theoretical basis for the further development of new strategies for the treatment of Alzheimer's disease.